HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

DARP-36aa selectively promotes survival and morphological development of cultured mesencephalic neurons.

Abstract
We examined the effects of DARP-36aa on the survival and morphological development of embryonic rat mesencephalic neurons. Treatment of mesencephalic cultures with DARP-36aa, a synthetic peptide corresponding to the N terminal of dopamine-releasing protein (DARP), resulted in a 1.8-fold increase in neuron survival. Morphological analysis revealed that DARP-36aa-treated neurons contained 48% more branching points per neuron compared with controls. DARP-36aa selectively affected mesencephalic cultures; diencephalic and C6 glioma cells were not affected by DARP-36aa treatments. Mesencephalic cultures were also incubated with polyclonal antibodies against DARP-36aa (anti-DARP-36aa) to assess the effect of immunoneutralization of endogenous DARP on these cells. Mesencephalic cultures treated with anti-DARP-36aa contained 43% fewer neurons, and the number of branching points per neuron was decreased by nearly twofold compared with cultures grown with medium alone. Similar to cultures treated with DARP-36aa, immunoneutralization of DARP had no effect on any parameters examined in primary diencephalic and C6 glioma cultures. Mesencephalic cultures maintained in the presence of DARP-36aa had a 3.2-fold increase in the number of tyrosine hydroxylase (TH)-immunoreactive neurons, whereas anti-DARP-36aa incubations decreased TH-immunoreactive neurons by 40% compared with control cultures. Finally, coincubation of the specific tyrosine kinase inhibitor genistein with DARP-36aa resulted in a complete attenuation of DARP-36aa-mediated neuron survival and development in mesencephalic cultures. The findings indicate that DARP-36aa is a novel neurotrophic peptide that selectively promotes the survival and development of mesencephalic neurons.
AuthorsSean M Smith, Victor D Ramirez
JournalThe Journal of neuroscience : the official journal of the Society for Neuroscience (J Neurosci) Vol. 23 Issue 1 Pg. 252-9 (Jan 01 2003) ISSN: 1529-2401 [Electronic] United States
PMID12514222 (Publication Type: Journal Article, Research Support, U.S. Gov't, P.H.S.)
Chemical References
  • Antibodies
  • Catecholamines
  • DARP-36aa
  • Enzyme Inhibitors
  • Glycoproteins
  • Intercellular Signaling Peptides and Proteins
  • Nerve Tissue Proteins
  • Peptide Fragments
  • dopamine-releasing factor, rat
  • Genistein
  • Tyrosine 3-Monooxygenase
Topics
  • Amino Acid Sequence
  • Animals
  • Antibodies (pharmacology)
  • Catecholamines (metabolism)
  • Cell Count
  • Cell Survival
  • Cells, Cultured
  • Diencephalon (cytology, embryology)
  • Enzyme Inhibitors (pharmacology)
  • Genistein (pharmacology)
  • Glycoproteins (chemistry)
  • Intercellular Signaling Peptides and Proteins
  • Mesencephalon (cytology, embryology)
  • Molecular Sequence Data
  • Nerve Tissue Proteins (chemistry, immunology, pharmacology)
  • Neurons (cytology, drug effects)
  • Peptide Fragments (chemistry, immunology, pharmacology)
  • Rats
  • Rats, Sprague-Dawley
  • Tumor Cells, Cultured
  • Tyrosine 3-Monooxygenase (analysis)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: